VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
UTMD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
UTMDUtah Medical Products, Inc.
$73.07$233M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksUTMDQuarterly Financials

Utah Medical Products, Inc. (UTMD) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Utah Medical Products, Inc. (UTMD) quarterly income statement — complete revenue, gross profit & net income history

UTMD Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue8.72M9.04M9.81M9.95M9.71M9.16M10.01M10.4M11.34M12.33M12.51M12.87M12.52M13.57M12.96M13.43M12.32M12.91M12.57M12.6M
Revenue Growth %-10.18%-1.24%-1.93%-4.3%-14.37%-25.74%-19.99%-19.17%-9.42%-9.14%-3.47%-4.19%1.6%5.11%3.05%6.54%12.4%7.53%19.97%43.44%
Cost of Goods Sold3.44M4.31M4.75M4.9M4.17M3.83M4.73M4.66M4.57M5.24M6.76M6.74M4.68M5.25M4.77M5.28M4.79M4.8M4.5M4.82M
COGS % of Revenue39.44%47.69%48.43%49.2%42.97%41.88%47.26%44.78%40.34%42.45%54.08%52.37%37.36%38.65%36.81%39.3%38.87%37.18%35.79%38.23%
Gross Profit5.28M4.73M5.06M5.06M5.54M5.32M5.28M5.74M6.77M7.1M5.74M6.13M7.84M8.33M8.19M8.15M7.53M8.11M8.07M7.79M
Gross Margin %60.56%52.31%51.57%50.8%57.03%58.12%52.74%55.22%59.66%57.55%45.92%47.63%62.64%61.35%63.19%60.7%61.13%62.82%64.21%61.77%
Gross Profit Growth %-4.62%-11.12%-4.11%-11.96%-18.15%-25.01%-8.1%-6.28%-13.73%-14.76%-29.86%-24.82%4.12%2.64%1.4%4.7%42.59%11.67%24.26%57.27%
Operating Expenses2.72M2.29M2.45M1.86M2.38M2.39M1.93M2.31M2.88M3.15M1.77M1.7M3.4M3.26M3.04M3.09M3.01M2.98M2.98M3.02M
OpEx % of Revenue31.15%25.31%24.96%18.69%24.56%26.13%19.33%22.16%25.42%25.57%14.18%13.24%27.19%23.99%23.5%23.04%24.43%23.1%23.66%23.96%
Selling, General & Admin2.56M2.08M2.28M1.73M1.42M7.6M1.76M2.05M1.36M11.04M1.64M1.57M1.26M11.24M2.93M2.96M2.89M11.49M2.85M2.89M
SG&A % of Revenue29.39%22.97%23.26%17.33%14.57%82.95%17.61%19.71%12.01%89.52%13.07%12.2%10.09%82.83%22.64%22.04%23.44%88.97%22.65%22.95%
Research & Development154K212K167K135K155K121K172K255K266K146K138K133K144K123K112K135K123K141K127K128K
R&D % of Revenue1.77%2.34%1.7%1.36%1.6%1.32%1.72%2.45%2.35%1.18%1.1%1.03%1.15%0.91%0.86%1.01%1%1.09%1.01%1.02%
Other Operating Expenses0000815K-1000K001000K-1000K001000K-1000K008K-1000K00
Operating Income2.56M2.44M2.61M3.2M3.15M2.93M3.34M3.44M3.88M3.94M3.97M4.42M4.44M5.07M5.14M5.06M4.52M5.13M5.1M4.76M
Operating Margin %29.41%27%26.61%32.11%32.47%31.99%33.41%33.06%34.24%31.98%31.74%34.39%35.46%37.35%39.68%37.66%36.7%39.72%40.55%37.81%
Operating Income Growth %-18.65%-16.66%-21.9%-7.04%-18.8%-25.71%-15.77%-22.31%-12.53%-22.21%-22.8%-12.5%-1.84%-1.17%0.84%6.13%16.31%19.86%42.12%141.02%
EBITDA3.25M3.19M3.36M3.94M3.87M3.65M4.08M4.13M4.57M4.97M5.75M6.2M6.2M6.81M6.89M6.83M6.33M6.93M6.93M6.61M
EBITDA Margin %37.3%35.24%34.28%39.6%39.9%39.82%40.81%39.72%40.26%40.3%46.01%48.22%49.54%50.15%53.15%50.89%51.38%53.68%55.11%52.44%
EBITDA Growth %-16.03%-12.61%-17.61%-4.6%-15.16%-26.62%-29.04%-33.41%-26.39%-27%-16.44%-9.21%-2.02%-1.79%-0.61%3.39%10.59%14.01%28.53%75.82%
D&A (Non-Cash Add-back)688K745K753K745K721K717K740K693K683K1.03M1.78M1.78M1.76M1.74M1.75M1.78M1.81M1.8M1.83M1.84M
EBIT3.18M3.11M3.31M3.84M3.47M3.27M4.18M4.21M4.63M4.6M4.78M5.17M4.85M5.74M5.34M5.2M4.53M5.15M5.16M4.83M
Net Interest Income617K0000000000000000000
Interest Income617K0000000000000000000
Interest Expense00000000000000000000
Other Income/Expense617K664K698K639K705K684K836K773K915K1.07M812K747K680K521K198K142K8K51K59K60K
Pretax Income3.18M3.11M3.31M3.83M3.86M3.61M4.18M4.21M4.8M5.02M4.78M5.17M5.12M5.59M5.34M5.2M4.53M5.18M5.16M4.83M
Pretax Margin %36.48%34.34%33.72%38.53%39.73%39.46%41.77%40.49%42.31%40.68%38.23%40.2%40.89%41.19%41.21%38.72%36.76%40.12%41.02%38.28%
Income Tax578K541K678K787K817K712K616K758K842K731K846K972K905K1.04M1.06M1.1M996K1.05M951K1.4M
Effective Tax Rate %18.16%17.42%20.49%20.52%21.18%19.7%14.74%18%17.55%14.57%17.7%18.79%17.68%18.53%19.84%21.08%21.99%20.25%18.44%28.99%
Net Income2.6M2.56M2.63M3.05M3.04M2.9M3.56M3.45M3.96M4.29M3.94M4.2M4.21M4.55M4.28M4.1M3.53M4.13M4.21M3.43M
Net Margin %29.86%28.36%26.81%30.62%31.32%31.69%35.61%33.2%34.89%34.75%31.47%32.64%33.66%33.56%33.04%30.56%28.68%32%33.46%27.18%
Net Income Growth %-14.37%-11.61%-26.16%-11.73%-23.13%-32.29%-9.45%-17.79%-6.12%-5.91%-8.06%2.36%19.24%10.24%1.76%19.76%16.87%21.1%43.4%160.93%
Net Income (Continuing)2.6M2.56M2.63M3.05M3.04M2.9M3.56M3.45M3.96M4.29M3.94M4.2M4.21M4.55M4.28M4.1M3.53M4.13M4.21M3.43M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.820.800.820.940.920.861.020.981.091.181.081.151.161.251.181.120.961.131.150.94
EPS Growth %-10.87%-6.98%-19.61%-4.08%-15.6%-27.12%-5.56%-14.78%-6.03%-5.6%-8.47%2.68%20.83%10.62%2.61%19.15%15.66%21.51%43.75%161.11%
EPS (Basic)0.820.770.790.920.920.861.020.951.091.181.081.161.161.261.181.130.971.131.150.94
Diluted Shares Outstanding3.19M3.2M3.21M3.25M3.31M3.39M3.48M3.53M3.62M3.63M3.64M3.64M3.64M3.63M3.63M3.65M3.67M3.67M3.66M3.65M
Basic Shares Outstanding3.19M3.31M3.31M3.31M3.31M3.39M3.48M3.62M3.62M3.63M3.63M3.63M3.63M3.63M3.63M3.64M3.65M3.65M3.65M3.65M
Dividend Payout Ratio37.98%38.09%37.55%32.84%33.44%35.77%29.53%31.31%27.53%24.99%27.22%25.48%25.39%23.07%24.58%25.83%-202.06%24.7%30.33%